Table 1.
SEC | SSP | |
---|---|---|
N | 79 | 10 |
Median age, years (IQR) | 57 (48–64.75) | 48 (41.5–57.25) |
Males (%) | 49 (62%) | 7 (70%) |
CUC (%) | 66 (84%) | 4 (40%) |
Median IBD duration at index, years (IQR) | 18 (10.5–29) | 9.5 (1.5–22.5) |
Extensive disease (%) | 61 (77%) | 7 (70%) |
PSC (%) | 23 (29%) | 0 (0%) |
Prior or synchronous CRN (%) | 27 (34%) | 6 (60%) |
Targeted index biopsy (%) | 30 (38%) | 10 (100%) |
Chromoendoscopy at index (%) | 16 (20%) | 2 (20%) |
CUC, chronic ulcerative colitis; PSC, primary sclerosing cholangitis; CRN, colorectal neoplasia.